aspartic acid has been researched along with fluvoxamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sawamura, K; Someya, T; Suzuki, Y | 1 |
| Harada, M; Kubo, H; Ohmori, T; Sumitani, S | 1 |
1 trial(s) available for aspartic acid and fluvoxamine
| Article | Year |
|---|---|
The effects of a 5-hydroxytryptamine 1A receptor gene polymorphism on the clinical response to fluvoxamine in depressed patients.
Topics: Adult; Antidepressive Agents, Second-Generation; Aspartic Acid; Depressive Disorder; Female; Fluvoxamine; Genotype; Glycine; Humans; Male; Receptor, Serotonin, 5-HT1A; Treatment Outcome | 2004 |
1 other study(ies) available for aspartic acid and fluvoxamine
| Article | Year |
|---|---|
Proton magnetic resonance spectroscopy reveals an abnormality in the anterior cingulate of a subgroup of obsessive-compulsive disorder patients.
Topics: Adult; Antipsychotic Agents; Aspartic Acid; Basal Ganglia; Benzodiazepines; Dominance, Cerebral; Dose-Response Relationship, Drug; Drug Therapy, Combination; Energy Metabolism; Female; Fluvoxamine; Frontal Lobe; Gyrus Cinguli; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nerve Net; Obsessive-Compulsive Disorder; Olanzapine; Paroxetine; Prefrontal Cortex; Risperidone; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2007 |